Silver Book Fact

Investments in cancer research and development between 1998 and 2000 has generated 23 million additional healthy years of life and $1.9 trillion of additional social value.

Lakdawala D, Sun E, Jena A, Reyes C, et al. An Economic Evaluation of the War on Cancer. J Health Econ. 2010; 29(3): 333-46. http://www.sciencedirect.com/science/article/B6V8K-4YH567G-1/2/88c88fbdd7f57d9fe08803ec85397bc0

Reference

Title
An Economic Evaluation of the War on Cancer
Publication
J Health Econ
Publication Date
2010
Authors
Lakdawala D, Sun E, Jena A, Reyes C, et al.
Volume & Issue
Volume 29, Issue 3
Pages
333-46
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Cancer patients in the U.S. experience greater survival gains than those in European countries, and the value of additional gains exceeds the additional cost of care in the U.S.  
  • New Drug Increases Brain Cancer Survival Rate: Temozolomide is the first new drug in over 30 years to treat glioblastoma, a severe form of brain cancer  
  • After one year, 73 percent of non-small-cell lung cancer patients with the EGFR genetic mutation who were treated with a tyrosine kinase inhibitor had survived, compared to 15 percent who…  
  • An experimental drug has been found to extend the lives of kidney patients by about 3.5 months–from 7 to just under 11. It has also been shown to delay…  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets CA125, a surface protein, or antigen, that is released in excess quantities by some ovarian cancers.…